Immune and endocrine function in burnout syndrome

Psychosomatic Medicine

Volumn 68, Issue 6, 2006, Pages 879-886

  Mommersteeg, Paula M C ^a   Heijnen, Cobi J ^b   Kavelaars, Annemieke ^b   Van Doornen, Lorenz J P ^a,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Department of Health Psychology ^*  (Netherlands)

Author keywords

Burnout; Cytokines; DHEAS; Glucocorticoids; IL 10; Monocyte

Indexed keywords

CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; INTERLEUKIN 10; PRASTERONE SULFATE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BURNOUT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOCRINE FUNCTION; FEMALE; HUMAN; HYDROCORTISONE RELEASE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFECTION; JOB STRESS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; SALIVA ANALYSIS; T LYMPHOCYTE;

ADULT; AGED; ANTIBODY FORMATION; BURNOUT, PROFESSIONAL; CASE-CONTROL STUDIES; CYTOKINES; ENDOCRINE SYSTEM; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; IMMUNITY, CELLULAR; INFLAMMATION; INTERLEUKIN-10; MALE; MIDDLE AGED; MONOCYTES;

EID: 33751343172     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.psy.0000239247.47581.0c     Document Type: Article

References (51)

1. Maslach C, Schaufeli WB, Leiter MP. Job burnout. Annu Rev Psychol 2001;52:397-422.
2. Schaufeli WB, Enzmann D. The Burnout Companion to Study and Practice: A Critical Analysis. London: Taylor & Francis, 1998.
3. ICD-10; International Statistical Classification of Diseases and Related Health Problems. Geneva: World Health Organization, 1994.
4. Reeves WC, Lloyd A, Vernon SD, Klimas N, Jason LA, Bleijenberg G, Evengard B, White PD, Nisenbaum R, Unger ER. Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Services Research 2003;3:25.
5. Appels A, Mulder P. Fatigue and heart disease. The association between 'vital exhaustion' and past, present and future coronary heart disease. J Psychosom Res 1989;33:727-38.
6. Shirom A. Reflections on the study of burnout. Work and Stress 2005;19:263-70.
7. Mohren DCL, Swaen GMH, Kant I, van Amelsvoort LGPM, Borm PJA, Galama JMD. Common infections and the role of burnout in a Dutch working population. J Psychosom Res 2003;55:201-8.
8. Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R. Psychoneuroimmunology and psychosomatic medicine: back to the future. Psychosom Med 2002;64:15-28.
9. Nakamura H, Nagase H, Yoshida M, Ogino K. Natural killer (NK) cell activity and NK cell subsets in workers with a tendency of burnout. J Psychosom Res 1999;46:569-78.
10. Bargellini A, Barbieri A, Rovesti S, Vivoli R, Roncaglia R, Borella P. Relation between immune variables and burnout in a sample of physicians. Occup Environ Med 2000;57:453-7.
11. Maier SF, Watkins LR. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 1998;105:83-107.
12. Elenkov IJ, Chrousos GP. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 2002;966:290-303.
13. Gaab J, Rohleder N, Heitz V, Engert V, Schad T, Schurmeyer TH, Ehlert U. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome. Psychoneuroendocrinology 2005;30:188-98.
14. Visser J, Graffelman W, Blauw B, Haspels I, Lentjes E, de Kloet ER, Nagelkerken L. LPS-induced IL-10 production in whole blood cultures from chronic fatigue syndrome patients is increased but supersensitive to inhibition by dexamethasone. J Neuroimmunol 2001;119:343-9.
15. Mommersteeg PMC, Heijnen CJ, Verbraak MJPM, van Doornen LJP. Clinical burnout is not reflected in the cortisol awakening response, the day-curve or the response to a low-dose dexamethasone suppression test. Psychoneuroendocrinology 2006;31:216-25.
16. Cole MA, Kim PJ, Kalman BA, Spencer RL. Dexamethasone suppression of corticosteroid secretion: evaluation of the site of action by receptor measures and functional studies. Psychoneuroendocrinology 2000;25:151-67.
17. Chen CC, Parker CR Jr. Adrenal androgens and the immune system. Seminars in reproductive medicine 2004;22:369-77.
18. Wolf OT, Kirschbaum C. Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans. Brain Res Brain Res Rev 1999;30:264-88.
19. Moch SL, Panz VR, Joffe BI, Havlik I, Moch JD. Longitudinal changes in pituitary-adrenal hormones in South African women with burnout. Endocrine 2003;21:267-72.
20. Grossi G, Perski A, Evengard B, Blomkvist V, Orth-Gomer K. Physiological correlates of burnout among women. J Psychosom Res 2003;55:309-16.
21. Young AH, Gallagher P, Porter RJ. Elevation of the cortisol- dehydroepiandrosterone ratio in drug-free depressed patients. Am J Psychiatry 2002;159:1237-9.
22. Wirtz PH, von Kanel R, Schnorpfeil P, Ehlert U, Frey K, Fischer JE. Reduced glucocorticoid sensitivity of monocyte interleukin-6 production in male industrial employees who are vitally exhausted. Psychosom Med 2003;65:672-8.
23. Visser J, Blauw B, Hinloopen B, Brommer E, de Kloet ER, Kluft C, Nagelkerken L. CD4 T lymphocytes from patients with chronic fatigue syndrome have decreased interferon-gamma production and increased sensitivity to dexamethasone. J Infect Dis 1998;177:451-4.
24. Kavelaars A, Kuis W, Knook L, Sinnema G, Heijnen CJ. Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome. J Clin Endocrinol Metab 2000;85:692-6.
25. Schaufeli W-B, Bakker A-B, Hoogduin K, Schaap C, Kladler A. On the clinical validity of the Maslach Burnout Inventory and the Burnout Measure. Psychology and Health 2001;16:565-82.
26. Bultmann U, de Vries M, Beurskens AJHM, Bleijenberg G, Vercoulen JHMM, Kant I. Measurement of prolonged fatigue in the working population: determination of a cutoff point for the checklist individual strength. J Occup Health Psychol 2000;5:411-6.
27. Arrindel WA, Ettema JHM. Dimensionele structuur, betrouwbaarheid en validiteit van de Nederlandse bewerking van de Symptom Checklist (SCL-90) [Dimensional structure, reliability and validity of the Dutch translation of the Symptom Checklist (SCL-90)]. Nederlands Tijdschrift voor de Psychologie, vol 36. Lisse, The Netherlands: Swets & Zeitlinger, 1981:77-108.
28. Diagnostic and Statistical Manual of Mental Disorders. Washington DC: American Psychiatric Association, 1994.
29. Mommersteeg PMC, Keijsers GPJ, Heijnen CJ, Verbraak MJPM, van Doornen LJP. Cortisol deviations in people with burnout before and after psychotherapy; a pilot study. Health Psychol 2006;25:243-8.
30. Canals J, Teresa Colomina M, Domingo JL, Domenech E. Influence of smoking and drinking habits on salivary cortisol levels. Personality and Individual Differences 1997;23:593-9.
31. Kirschbaum C, Kudielka BM, Gaab J, Schommer N, Hellhammer DH. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosom Med 1999;61:154-62.
32. Pruessner JC, Wolf OT, Hellhammer DH, Buske Kirschbaum A, von Auer K, Jobst S, Kaspers F, Kirschbaum C. Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci 1997;61:2539-49.
33. Schaufeli WB, Van Dierendonck D. UBOS, Utrechtse Burnout Schaal [UBOS, the Dutch Translation of the Maslach Burnout Inventory (MBI)]. Lisse, The Netherlands: Swets & Zeitlinger BV, 2000.
34. Vercoulen JHMM, Alberts M, Bleijenberg Gvd. The checklist individual strength. Gedragstherapie 1999;32:131-6.
35. Meijman TF, Thunnissen MJ, de Vries-Griever AG. The after-effects of a prolonged period of day-sleep on subjective sleep quality. Work and Stress 1990;4:65-70.
36. Bouma J, Ranchor AV, Sanderman R, Sonderen Ev. Het meten van symptomen van depressie met de CES-D [Measuring Symptoms of Depression With the CES-D]. Groningen: Noordelijk Centrum voor Gezondheidsvraagstukken, 1995:1-24.
37. Shirtcliff EA, Granger DA, Schwartz E, Curran MJ. Use of salivary biomarkers in biobehavioral research: cotton-based sample collection methods can interfere with salivary immunoassay results. Psychoneuroendocrinology 2001;26:165-73.
38. Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 2003;28:916-31.
39. Kudielka BM, Broderick JE, Kirschbaum C. Compliance with saliva sampling protocols: electronic monitoring reveals invalid cortisol day-time profiles in noncompliant subjects. Psychosom Med 2003;65:313-9.
40. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
41. Lyall M, Peakman M, Wessely S. A systematic review and critical evaluation of the immunology of chronic fatigue syndrome. J Psychosom Res 2003;55:79-90.
42. Patarca R. Cytokines and chronic fatigue syndrome. Ann N Y Acad Sci 2001;933:185-200.
43. Gupta S, Aggarwal S, See D, Starr A. Cytokine production by adherent and non-adherent mononuclear cells in chronic fatigue syndrome. J Psychiatr Res 1997;31:149-56.
44. van der Ven A, van Diest R, Hamulyak K, Maes M, Bruggeman C, Appels A. Herpes viruses, cytokines, and altered hemostasis in vital exhaustion. Psychosom Med 2003;65:194-200.
45. Cohen S, Frank E, Doyle WJ, Skoner DP, Rabin BS, Gwaltney JM Jr. Types of stressors that increase susceptibility to the common cold in healthy adults. Health Psychol 1998;17:214-23.
46. Stockl J, Vetr H, Majdic O, Zlabinger G, Kuechler E, Knapp W. Human major group rhinoviruses downmodulate the accessory function of monocytes by inducing IL-10. J Clin Invest 1999;104:957-65.
47. Gwaltney J, Jack M. Clinical significance and pathogenesis of viral respiratory infections. Am J Med 2002;112:13-8.
48. Glaser R, Padgett DA, Litsky ML, Baiocchi RA, Yang EV, Chen M, Yeh P-E, Klimas NG, Marshall GD, Whiteside T. Stress-associated changes in the steady-state expression of latent Epstein-Barr virus: implications for chronic fatigue syndrome and cancer. Brain Behav Immun 2005;19:91-103.
49. Kroboth P, Salek F, Pittenger A, Fabian T, Frye R. DHEA and DHEA-S. A review. J Clin Pharmacol 1999;39:327-48.
50. Assies J, Visser I, Nicolson NA, Eggelte TA, Wekking EM, Huyser J, Lieverse R, Schene AH. Elevated salivary dehydroepiandrosterone-sulfate but normal cortisol levels in medicated depressed patients: preliminary findings. Psychiatry Res 2004;128:117-22.
51. Cheng G-F, Tseng J. Regulation of murine interleukin-10 production by dehydroepiandrosterone. J Interferon Cytokine Res 2000;20:471-8.